A discussion at last week's Precision Medicine Tri-Con demonstrated that stakeholders are narrowing in on the challenges to realizing the promise of solid tumor MRD.
Genomic Screening Uncovers Actionable Results in Thousands of Exome-Sequenced MyCode Participants
Using exome sequence profiles for some 175,000 individuals, researchers returned genetic risk data to 5,052 Geisinger MyCode Community Health Initiative participants.
Akoya Biosciences Fourth Quarter Revenues Down 19 Percent
Pending acquisition by Quanterix, which was announced in January, the spatial biology firm did not host an earnings call or issue forward guidance for 2025.
UK Prime Minister Plans to Abolish NHS England
The abolishment of the agency is aimed at reducing bureaucracy and the duplication of services provided by the UK Department of Health and Social Care.
Tempus AI Acquires Clinical Trial Patient Matching Firm Deep 6 AI
Pasadena, California-based Deep 6 AI matches patients to clinical trials by mining real-time structured and unstructured electronic medical record data.